Stocks Health care CGC
NASDAQ · Health careCanopy Growth Corp (CGC)
We have not processed filings for Canopy Growth Corp yet. This page fills in on its own once we have read them.
Key facts about Canopy Growth Corp
- Net worth
- Canopy Growth Corp has a market value (market cap) of $263.5M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 6, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Canopy Growth Corp's next report is expected around February 5, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Canopy Growth Corp does
Canopy Growth Corp is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker CGC.
Earnings: every quarter and the next report date
Latest SEC filings
What Canopy Growth Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 6, 2026
- November 6, 2026Quarterly report 10-Q · period to September 30, 2026
- October 23, 2026
- October 16, 2026Additional proxy material DEFA14A
- October 16, 2026
- October 6, 2026Additional proxy material DEFA14A
- September 25, 2026Additional proxy material DEFA14A
- September 15, 2026Additional proxy material DEFA14A
- August 17, 2026Additional proxy material DEFA14A
- August 14, 2026Additional proxy material DEFA14A
Insider trades
What the people running Canopy Growth Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $87.2K worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 28, 2026 | Atkins M ShanDirector | Sold | 3,096 | $2.9K |
| September 28, 2026 | Bayern JosephDirector | Sold | 3,096 | $2.9K |
| September 28, 2026 | Lazzarato David AngeloDirector | Sold | 22,380 | $20.7K |
| September 28, 2026 | Yanofsky TheresaDirector | Sold | 14,920 | $13.8K |
| September 17, 2026 | Stewart Thomas CarltonSee Remarks | Sold | 25,755 | $24K |
| August 24, 2026 | Stewart Thomas CarltonSee Remarks | Sold | 2,231 | $3.3K |
| August 24, 2026 | Gedeon ChristelleSee Remarks | Sold | 13,344 | $19.6K |
| June 26, 2026 | Lazzarato David AngeloDirector | Sold | 22,674 | $20.9K |
Who owns CGC
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
6 insiders reported holding 1,887,000 shares in total, about $1.2M at the last price.
| Holder | Shares |
|---|---|
| Gedeon ChristelleSee Remarks | 692,162 |
| Stewart Thomas CarltonSee Remarks | 588,412 |
| Lazzarato David AngeloDirector | 189,479 |
| Atkins M ShanDirector | 143,421 |
| Bayern JosephDirector | 142,031 |
| Yanofsky TheresaDirector | 131,495 |
Questions about CGC
What does Canopy Growth Corp do?
Canopy Growth Corp is a company in the Health care sector, listed on NASDAQ as CGC. Its shares trade on NASDAQ under the ticker CGC.
What is Canopy Growth Corp's net worth?
Canopy Growth Corp has a market value (market cap) of $263.5M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.
When did Canopy Growth Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 6, 2026. It covers the period to September 30, 2026.
When is Canopy Growth Corp's next earnings report?
Canopy Growth Corp's next report is expected around February 5, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare CGC with
Follow CGC
Get an email when Canopy Growth Corp files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Canopy Growth Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.